BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28694115)

  • 21. Development of an indigenous low-cost multichannel cylinder applicator for vaginal tumors.
    Bajwa HK; Singareddy R; Talluri AK; Guntupalli R; Raju AK; Sresty M; Ahmed A
    Brachytherapy; 2020; 19(5):674-678. PubMed ID: 32540330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
    Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
    Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
    Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
    Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life.
    Sanmamed N; Chung P; Berlin A; Adleman J; Borg J; Lao B; Ghai S; Weersink R; Simeonov A; Rink A; Menard C; Helou J
    Brachytherapy; 2019; 18(4):477-483. PubMed ID: 31109872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient's specific integration of OAR doses (D2 cc) from EBRT and 3D image-guided brachytherapy for cervical cancer.
    Gelover E; Katherine C; Mart C; Sun W; Kim Y
    J Appl Clin Med Phys; 2018 Mar; 19(2):83-92. PubMed ID: 29349933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.
    Damato AL; Townamchai K; Albert M; Bair RJ; Cormack RA; Jang J; Kovacs A; Lee LJ; Mak KS; Mirabeau-Beale KL; Mouw KW; Phillips JG; Pretz JL; Russo AL; Lewis JH; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):674-81. PubMed ID: 24803035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
    Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
    Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
    Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.
    Simpson DR; Scanderbeg DJ; Carmona R; McMurtrie RM; Einck J; Mell LK; McHale MT; Saenz CC; Plaxe SC; Harrison T; Mundt AJ; Yashar CM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):150-7. PubMed ID: 26130230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
    Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
    Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
    Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
    Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.
    Peters M; van der Voort van Zyp J; Hoekstra C; Westendorp H; van de Pol S; Moerland M; Maenhout M; Kattevilder R; van Vulpen M
    Radiother Oncol; 2015 Nov; 117(2):262-9. PubMed ID: 26349590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated high-dose rate brachytherapy treatment planning for a single-channel vaginal cylinder applicator.
    Zhou Y; Klages P; Tan J; Chi Y; Stojadinovic S; Yang M; Hrycushko B; Medin P; Pompos A; Jiang S; Albuquerque K; Jia X
    Phys Med Biol; 2017 Jun; 62(11):4361-4374. PubMed ID: 28244879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method.
    Hayashi K; Isohashi F; Akino Y; Wakai N; Mabuchi S; Suzuki O; Seo Y; Ootani Y; Sumida I; Yoshioka Y; Kimura T; Ogawa K
    J Radiat Res; 2015 May; 56(3):546-52. PubMed ID: 25678538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an active magnetic resonance tracking system for interstitial brachytherapy.
    Wang W; Viswanathan AN; Damato AL; Chen Y; Tse Z; Pan L; Tokuda J; Seethamraju RT; Dumoulin CL; Schmidt EJ; Cormack RA
    Med Phys; 2015 Dec; 42(12):7114-21. PubMed ID: 26632065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.